Inicio › Enfermedad cardiovascular › Washington
Ensayos clínicos de Enfermedad cardiovascular en Washington
15 estudios sobre Enfermedad cardiovascular buscan participantes en Washington.
Ciudades en Washington
Texto oficial del estudio (inglés)
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
- Universal Research Group, LLC, Tacoma
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 30 sept 2026 · NCT07064473Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention
- MultiCare Institute for Research and Innovation, Puyallup
- MultiCare Institute for Research and Innovation, Tacoma
ReclutandoFase 4
Edades de 18 en adelante · Todos los sexos · Actualizado el 28 sept 2026 · NCT06909565A Study to See if Lepodisiran Can Reduce Plaque in Coronary Arteries of Adults With Elevated Lp(a) Who Have Had Heart Events or Are at High Risk
- Eastside Research Associates, Redmond
ReclutandoFase 3
Edades de 45 a 80 · Todos los sexos · Actualizado el 22 sept 2026 · NCT07613294Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease
- Clinical Trial Site, Bellevue
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 18 sept 2026 · NCT07181109Product Surveillance Registry
- Bremerton
- Seattle
- Spokane
ReclutandoEstudio observacional
Todas las edades · Todos los sexos · Actualizado el 18 sept 2026 · NCT01524276Transcatheter Mitral Valve Replacement With the Medtronic Intrepid™ TMVR System in Patients With Severe Symptomatic Mitral Regurgitation.
- University of Washington (UW) Medical Center, Seattle
- Providence Sacred Heart Medical Center & Children's Hospital, Spokane
Reclutando
Edades de 18 en adelante · Todos los sexos · Actualizado el 15 sept 2026 · NCT03242642An Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to Evaluate Long-term Safety and Tolerability of Pelacarsen (TQJ230)
- Harborview Medical Center, Seattle
- Swedish Medical Center-Cardiovascular Research, Seattle
- Univ of Washington Medical Center, Seattle
ReclutandoFase 3
Edades de 18 a 100 · Todos los sexos · Actualizado el 4 sept 2026 · NCT07517263A Study About How Blood Cell Growth Patterns Relate to Heart Health After Treatment for Hodgkin Lymphoma
- Seattle Children's Hospital, Seattle
ReclutandoEstudio observacional
Edades de 7 en adelante · Todos los sexos · Actualizado el 25 ago 2026 · NCT05705531A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event
- Research Site, Puyallup
- Research Site, Redmond
- Research Site, Renton
- y 2 más
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 24 ago 2026 · NCT07000357OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular Events
- Western Washington Medical Group, Everett
- Rainier Clinical Research Center, Renton
ReclutandoFase 3
Edades de 50 a 105 · Todos los sexos · Actualizado el 21 ago 2026 · NCT07136012Global Paradise System US Post Approval Study
- Swedish Medical Center, Seattle
ReclutandoEstudio observacional
Edades de 18 en adelante · Todos los sexos · Actualizado el 12 ago 2026 · NCT06297291ELEVATE-HFpEF Clinical Study
- Saint Joseph Medical Center (Tacoma WA), Tacoma
Reclutando
Edades de 40 en adelante · Todos los sexos · Actualizado el 3 ago 2026 · NCT06678841PROACTIVE-HF-2 Trial Heart Failure NYHA Class II and III
- Providence Everett, Everett
Reclutando
Edades de 18 en adelante · Todos los sexos · Actualizado el 29 jun 2026 · NCT05934487Sotagliflozin to Slow Kidney Function Decline in Persons With Type 1 Diabetes and Diabetic Kidney Disease
- University of Washington, Seattle
- Providence Sacred Heart Medical Center, Spokane
ReclutandoFase 3
Edades de 18 a 75 · Todos los sexos · Actualizado el 24 mar 2026 · NCT06217302MANATEE-T1D: Metformin ANd AutomaTEd Insulin Delivery System Effects on Renal Vascular Resistance, Insulin Sensitivity, and Cardiometabolic Function in Youth With Type 1 Diabetes
- Seattle Children's Hospital, Seattle
ReclutandoFase 1
Edades de 12 a 25 · Todos los sexos · Actualizado el 13 jun 2025 · NCT05065372De ClinicalTrials.gov, datos obtenidos el 1 oct 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.